How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?

This publication has 12 references indexed in Scilit:

• Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry
  Catheterization and Cardiovascular Interventions, 2015
• Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold
  JACC: Cardiovascular Interventions, 2014
• Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
  EuroIntervention, 2014
• Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation
  EuroIntervention, 2014
• Incidence, Predictors, Morphological Characteristics, and Clinical Outcomes of Stent Edge Dissections Detected by Optical Coherence Tomography
  JACC: Cardiovascular Interventions, 2013
• Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model
  JACC: Cardiovascular Interventions, 2013
• Bioresorbable Polymeric Vascular Scaffolds
  Circulation: Cardiovascular Interventions, 2011
• Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model
  Circulation, 2010
• A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
  The Lancet, 2008
• Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation†
  European Heart Journal, 2005